ArticleContemporary clinical trials communications2026
Addressing financial and health-related social needs among patients with cancer: Study protocol for CAN-ASSIST pilot clinical trial.
Article in Contemporary clinical trials communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06430840 (Addressing Financial and Social Needs Among Patients With Cancer), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Addressing Financial and Social Needs Among Patients With Cancer
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background: Financial hardship and health-related social needs (HRSNs) are prevalent among cancer patients and contribute to disparities in outcomes. Addressing these issues can reduce harm, yet routine screening and intervention remains underutilized. Navigator-led interventions such as combining out-of-pocket cost (OOPC) communication and financial navigation (CostCOM) have shown promise, but face implementation barriers due to navigator shortages. It is unclear whether financial education and resource access alone (FinEd), without navigator support, can meet patients' needs. Method: We propose a three-arm pilot randomized controlled trial comparing FinEd, enhanced usual care (EUC) and CostCOM in 90 newly diagnosed cancer patients undergoing systemic or radiation therapy who screen positive for financial hardship or HRSNs. FinEd includes (1) a list of local/national resources for financial and HRSNs support, and (2) educational materials on health insurance, delivered via mail and a one-time phone/video session with a study coordinator. CostCOM includes (1) systemic therapy OOPC estimates, (2) financial navigation to identify assistance programs, and (3) financial counseling, delivered over two phone/video sessions by a financial navigator. EUC includes study-specific identification of financial hardship and HRSNs. Our goals are to investigate preliminary efficacy of the three arms within six months post-randomization on cost-related care non-adherence (primary outcome), treatment completion, missed appointments, financial worry, material hardship, insurance literacy, quality of life, and sleep quality. We will evaluate patient experience with FinEd using qualitative interviews. Conclusion: This study will support feasibility for a larger trial, and provide initial efficacy estimates comparing FinEd vs. EUC vs. CostCOM in improving cancer outcomes. Trial registration: Clinicaltrials.gov NCT06430840; registered 5/24/2024; https://clinicaltrials.gov/study/NCT06430840?cond=NCT06430840&rank=1.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.